This inventor holds 1 USPTO granted patent. Top assignee: Analogic Corporation. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: John Fallon - Innovator in Particle Agglutination Assay Systems
Introduction
John Fallon is a notable inventor based in Andover, MA (US). He has made significant contributions to the field of assay systems, particularly with his innovative approach to analyzing fluid samples. His work has implications in various scientific and medical applications.
Latest Patents
John Fallon holds a patent for a Particle Agglutination Assay System. This system is designed for assaying a fluid sample for one or more types of analytes. It employs finely divided polystyrene spheroidal particles, each class being limited to a predetermined specific narrow range of particle diameters. The particles are coated with specific reactants unique to each class. When mixed with the sample, these coated particles react to form conjugates with any analyte present. The mixture is then irradiated with bursts of ultrasound swept over a range of frequencies resonant to the expected conjugate sizes. The presence of the conjugates, and therefore the analyte, is detected by measuring selective absorption or scattering of waves of frequencies to which the conjugates are resonant.
Career Highlights
John Fallon is currently employed at Analogic Corporation, where he continues to develop and refine his innovative technologies. His work at Analogic Corporation has allowed him to contribute to advancements in medical imaging and diagnostic systems.
Collaborations
Throughout his career, John has collaborated with esteemed colleagues such as Gopal Gopinathan and Edmund F Becker. These collaborations have fostered a productive environment for innovation and development in their respective fields.
Conclusion
John Fallon is a distinguished inventor whose work in particle agglutination assay systems showcases his commitment to advancing scientific research and medical diagnostics. His contributions continue to impact the industry positively.
